Science Explorer Back to mapMap
Discussion
Company · Cambridge · United Kingdom

AstraZeneca (United Kingdom)

In research, AstraZeneca (United Kingdom) stands highest in Health Sciences (#265 of 9,902 worldwide), Medicine (#278 of 8,541 worldwide) and Life Sciences (#249 of 6,403 worldwide), 2022-now. Relative to its size it is most specialised in Pharmaceutical Science, Nephrology and Oncology (Pharmaceutical Science is 10.0× its share of world research).

astrazeneca.comROR OpenAlex
World rank, 2022-now
#514
of 22,385 · #433 all time
Rank in United Kingdom
#37
of 862
Research works
20k
▲ 16% vs 2018-21
Citations
725k
36.2 per fractional work
Top-10% rate
16.6%
all institutions 10.0%
vs its own fields
1.24×
1.00× is exactly expected
Open access
38%
world 40%
International
49%
world 18%
AstraZeneca (United Kingdom)

What is AstraZeneca (United Kingdom) known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #265 of 9,902 18.3%1,873 #233
MedicineField #278 of 8,541 18.2%1,793 #244
Life SciencesDomain #249 of 6,403 17.2%909 #222
Biochemistry, Genetics and Molecular BiologyField #125 of 2,964 18.5%637 #146
Molecular BiologySubfield #101 of 1,880 18.0%448 #126
Physical SciencesDomain #929 of 10,670 14.3%553 #712
Pulmonary and Respiratory MedicineSubfield #91 of 1,037 20.3%375 #138
OncologySubfield #115 of 755 16.0%284 #126
ChemistryField #251 of 1,299 10.9%162 #157
SurgerySubfield #346 of 1,532 18.3%98 #256

Each strip is that field's whole ranked pool, with the notch where AstraZeneca (United Kingdom) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Health Sciences#233 #265
  2. Medicine#244 #278
  3. Life Sciences#222 #249
  4. Biochemistry, Genetics and Molecular Biology#146 #125
  5. Molecular Biology#126 #101
  6. Physical Sciences#712 #929
  7. Pulmonary and Respiratory Medicine#138 #91
  8. Oncology#126 #115
  9. Chemistry#157 #251
  10. Surgery#256 #346
all time2022-now, better2022-now, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

Which fields of science does AstraZeneca (United Kingdom) work in?

In 2022-now, 54% of research at AstraZeneca (United Kingdom) is in Health Sciences, 26% in Life Sciences. Its largest fields are Medicine (51%), Biochemistry, Genetics and Molecular Biology (19%), Chemistry (5%). It does 2.3× the world's share of Health Sciences.

Health Sciences: 2,145 fractional works · 53.5% of its workMedicine: 2,052 fractional works · 51.2% of its workPulmonary and Respiratory Medicine: 443 fractional works · 11.0% of its workOncology: 332 fractional works · 8.3% of its workPhysiology: 153 fractional works · 3.8% of its workRadiology, Nuclear Medicine and Imaging: 126 fractional works · 3.1% of its workSurgery: 109 fractional works · 2.7% of its workCardiology and Cardiovascular Medicine: 105 fractional works · 2.6% of its workEpidemiology: 97 fractional works · 2.4% of its workEndocrinology, Diabetes and Metabolism: 90 fractional works · 2.2% of its workRheumatology: 72 fractional works · 1.8% of its workNephrology: 72 fractional works · 1.8% of its workGenetics: 50 fractional works · 1.3% of its workInfectious Diseases: 49 fractional works · 1.2% of its workPublic Health, Environmental and Occupational Health: 47 fractional works · 1.2% of its workPathology and Forensic Medicine: 44 fractional works · 1.1% of its workHematology: 40 fractional works · 1.0% of its workNeurology: 30 fractional works · 0.7% of its workPediatrics, Perinatology and Child Health: 26 fractional works · 0.7% of its workHepatology: 26 fractional works · 0.6% of its workPharmacology: 21 fractional works · 0.5% of its workImmunology and Allergy: 18 fractional works · 0.5% of its workReproductive Medicine: 13 fractional works · 0.3% of its workDermatology: 12 fractional works · 0.3% of its workFamily Practice: 9 fractional works · 0.2% of its workOtorhinolaryngology: 9 fractional works · 0.2% of its workPsychiatry and Mental health: 9 fractional works · 0.2% of its workSmaller subfields together: 52 fractional works · 1.3% of its workHealth Professions: 72 fractional works · 1.8% of its workGeneral Health Professions: 37 fractional works · 0.9% of its workEmergency Medical Services: 12 fractional works · 0.3% of its workHealth Information Management: 10 fractional works · 0.3% of its workSmaller subfields together: 13 fractional works · 0.3% of its workNursing: 10 fractional works · 0.2% of its workNutrition and Dietetics: 9 fractional works · 0.2% of its workVeterinary: 8 fractional works · 0.2% of its workDentistry: 3 fractional works · 0.1% of its workLife Sciences: 1,051 fractional works · 26.2% of its workBiochemistry, Genetics and Molecular Biology: 747 fractional works · 18.6% of its workMolecular Biology: 526 fractional works · 13.1% of its workGenetics: 76 fractional works · 1.9% of its workCancer Research: 75 fractional works · 1.9% of its workBiophysics: 19 fractional works · 0.5% of its workCell Biology: 16 fractional works · 0.4% of its workBiotechnology: 10 fractional works · 0.2% of its workPhysiology: 9 fractional works · 0.2% of its workSmaller subfields together: 17 fractional works · 0.4% of its workImmunology and Microbiology: 176 fractional works · 4.4% of its workImmunology: 167 fractional works · 4.2% of its workSmaller subfields together: 9 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 77 fractional works · 1.9% of its workPharmaceutical Science: 43 fractional works · 1.1% of its workPharmacology: 30 fractional works · 0.7% of its workSmaller subfields together: 4 fractional works · 0.1% of its workNeuroscience: 28 fractional works · 0.7% of its workCellular and Molecular Neuroscience: 11 fractional works · 0.3% of its workSmaller subfields together: 16 fractional works · 0.4% of its workAgricultural and Biological Sciences: 24 fractional works · 0.6% of its workAnimal Science and Zoology: 10 fractional works · 0.2% of its workSmaller subfields together: 14 fractional works · 0.3% of its workPhysical Sciences: 630 fractional works · 15.7% of its workChemistry: 183 fractional works · 4.6% of its workOrganic Chemistry: 110 fractional works · 2.8% of its workSpectroscopy: 44 fractional works · 1.1% of its workInorganic Chemistry: 11 fractional works · 0.3% of its workAnalytical Chemistry: 8 fractional works · 0.2% of its workPhysical and Theoretical Chemistry: 8 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 0.0% of its workEngineering: 116 fractional works · 2.9% of its workBiomedical Engineering: 68 fractional works · 1.7% of its workMechanical Engineering: 9 fractional works · 0.2% of its workElectrical and Electronic Engineering: 8 fractional works · 0.2% of its workSmaller subfields together: 31 fractional works · 0.8% of its workComputer Science: 115 fractional works · 2.9% of its workComputational Theory and Mathematics: 65 fractional works · 1.6% of its workArtificial Intelligence: 35 fractional works · 0.9% of its workSmaller subfields together: 15 fractional works · 0.4% of its workMathematics: 70 fractional works · 1.8% of its workStatistics and Probability: 60 fractional works · 1.5% of its workSmaller subfields together: 10 fractional works · 0.2% of its workMaterials Science: 69 fractional works · 1.7% of its workMaterials Chemistry: 49 fractional works · 1.2% of its workBiomaterials: 14 fractional works · 0.3% of its workSmaller subfields together: 7 fractional works · 0.2% of its workEnvironmental Science: 48 fractional works · 1.2% of its workHealth, Toxicology and Mutagenesis: 17 fractional works · 0.4% of its workEnvironmental Chemistry: 15 fractional works · 0.4% of its workSmaller subfields together: 16 fractional works · 0.4% of its workPhysics and Astronomy: 14 fractional works · 0.4% of its workChemical Engineering: 7 fractional works · 0.2% of its workEarth and Planetary Sciences: 4 fractional works · 0.1% of its workEnergy: 4 fractional works · 0.1% of its workSocial Sciences: 181 fractional works · 4.5% of its workEconomics, Econometrics and Finance: 103 fractional works · 2.6% of its workEconomics and Econometrics: 101 fractional works · 2.5% of its workSmaller subfields together: 2 fractional works · 0.0% of its workSocial Sciences: 36 fractional works · 0.9% of its workSociology and Political Science: 22 fractional works · 0.5% of its workSmaller subfields together: 14 fractional works · 0.3% of its workDecision Sciences: 19 fractional works · 0.5% of its workStatistics, Probability and Uncertainty: 11 fractional works · 0.3% of its workSmaller subfields together: 8 fractional works · 0.2% of its workPsychology: 14 fractional works · 0.4% of its workBusiness, Management and Accounting: 8 fractional works · 0.2% of its workArts and Humanities: 1 fractional works · 0.0% of its workALL ITS WORKAstraZeneca(United Kingdom)4,007fractional works, 2022-now
Life Sciences26%Physical Sciences16%Health Sciences54%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 26 fields, with their numbers
  1. Health Sciences2,14553.5%
    1. Medicine2,05251.2%
    2. Health Professions721.8%
    3. Nursing100.2%
    4. Veterinary80.2%
    5. Dentistry30.1%
  2. Life Sciences1,05126.2%
    1. Biochemistry, Genetics and Molecular Biology74718.6%
    2. Immunology and Microbiology1764.4%
    3. Pharmacology, Toxicology and Pharmaceutics771.9%
    4. Neuroscience280.7%
    5. Agricultural and Biological Sciences240.6%
    1. Chemistry1834.6%
    2. Engineering1162.9%
    3. Computer Science1152.9%
    4. Mathematics701.8%
    5. Materials Science691.7%
    6. Environmental Science481.2%
    7. Physics and Astronomy140.4%
    8. Chemical Engineering70.2%
    9. Earth and Planetary Sciences40.1%
    10. Energy40.1%
    1. Economics, Econometrics and Finance1032.6%
    2. Social Sciences360.9%
    3. Decision Sciences190.5%
    4. Psychology140.4%
    5. Business, Management and Accounting80.2%
    6. Arts and Humanities10.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does AstraZeneca (United Kingdom) specialise in?

Where its research is concentrated relative to its size: Pharmaceutical Science takes 10.0× the share of its output that it takes of world research.

  1. Pharmaceutical ScienceSubfield · 42.8 works10×
  2. NephrologySubfield · 71.5 works8.2×
  3. OncologySubfield · 331.9 works7.4×
  4. Pulmonary and Respiratory MedicineSubfield · 442.8 works7.2×
  5. Statistics and ProbabilitySubfield · 60.2 works7.1×
  6. ImmunologySubfield · 167.2 works6.1×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.12× its world share, 24 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.49× its world share, 747 worksBiochemistry, Geneti…Immunology and Microbiology: 4.36× its world share, 176 worksImmunology and Micro…Neuroscience: 0.43× its world share, 28 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.46× its world share, 77 worksPharmacology, Toxico…Chemical Engineering: 0.53× its world share, 7 worksChemical EngineeringChemistry: 2.92× its world share, 183 worksChemistryComputer Science: 0.37× its world share, 115 worksComputer ScienceEarth and Planetary Sciences: 0.06× its world share, 4 worksEarth and Planetary …Energy: 0.10× its world share, 4 worksEnergyEngineering: 0.19× its world share, 116 worksEngineeringEnvironmental Science: 0.24× its world share, 48 worksEnvironmental ScienceMaterials Science: 0.49× its world share, 69 worksMaterials ScienceMathematics: 1.49× its world share, 70 worksMathematicsPhysics and Astronomy: 0.16× its world share, 14 worksPhysics and AstronomyDentistry: 0.17× its world share, 3 worksDentistryHealth Professions: 0.68× its world share, 72 worksHealth ProfessionsMedicine: 2.66× its world share, 2,052 worksMedicineNursing: 0.49× its world share, 10 worksNursingVeterinary: 1.53× its world share, 8 worksVeterinaryArts and Humanities: 0.01× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 0.06× its world share, 8 worksBusiness, Management…Decision Sciences: 0.50× its world share, 19 worksDecision SciencesEconomics, Econometrics and Finance: 1.20× its world share, 103 worksEconomics, Econometr…Psychology: 0.12× its world share, 14 worksPsychologySocial Sciences: 0.07× its world share, 36 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.5×. Every wedge is a field page.

All 26 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics5.46×77 works
  2. Immunology and Microbiology4.36×176 works
  3. Biochemistry, Genetics and Molecular Biology3.49×747 works
  4. Chemistry2.92×183 works
  5. Medicine2.66×2,052 works
  6. Veterinary1.53×8 works
  7. Mathematics1.49×70 works
  8. Economics, Econometrics and Finance1.20×103 works
  9. Health Professions0.68×72 works
  10. Chemical Engineering0.53×7 works
  11. Decision Sciences0.50×19 works
  12. Materials Science0.49×69 works
  13. Nursing0.49×10 works
  14. Neuroscience0.43×28 works
  15. Computer Science0.37×115 works
  16. Environmental Science0.24×48 works
  17. Engineering0.19×116 works
  18. Dentistry0.17×3 works
  19. Physics and Astronomy0.16×14 works
  20. Agricultural and Biological Sciences0.12×24 works
  21. Psychology0.12×14 works
  22. Energy0.10×4 works
  23. Social Sciences0.07×36 works
  24. Earth and Planetary Sciences0.06×4 works
  25. Business, Management and Accounting0.06×8 works
  26. Arts and Humanities0.01×1 works

Who are the top researchers at AstraZeneca (United Kingdom)?

Ranked on the quality score, Mark J. O’Connor, Slavé Petrovski and Simon T. Barry lead among researchers whose main affiliation is AstraZeneca (United Kingdom).

  1. 1 Mark J. O’Connor United Kingdom · #3,405 worldwide 22k citations · 449 works
  2. 2 Slavé Petrovski United Kingdom · #8,356 worldwide 27k citations · 261 works
  3. 3 Simon T. Barry United Kingdom · #14,680 worldwide 15k citations · 586 works
  4. 4 Natasha A. Karp United Kingdom · #26,984 worldwide 28k citations · 171 works
  5. 5 Ross A. Stewart United Kingdom · #37,243 worldwide 5.5k citations · 125 works
  6. 6 Alan Lau United Kingdom · #39,099 worldwide 10k citations · 112 works
  7. 7 Jonathan D. Tugwood United Kingdom · #51,311 worldwide 10k citations · 95 works
  8. 8 Paul D. Smith United Kingdom · #53,591 worldwide 14k citations · 272 works
  9. 9 Susan E. Critchlow United Kingdom · #62,320 worldwide 7.9k citations · 308 works
  10. 10 Viia Valge-Archer United Kingdom · #66,255 worldwide 5.5k citations · 142 works
All ranked researchers at AstraZeneca (United Kingdom)

What are the most cited papers from AstraZeneca (United Kingdom)?

The most cited paper from AstraZeneca (United Kingdom) is "Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines" (Clotilde Théry et al., 2018), with 11,535 citations. Next come "A roadmap for graphene" (9,276) and "A comparison of normalization methods for high density oligonucleotide array data based on variance and bias" (8,511).

Most cited papers
#PaperReleasedCitations
1 Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines Clotilde Théry et al. · Journal of Extracellular Vesicles Open access382 authors 23 Nov 2018 11,535
2 A roadmap for graphene Kostya S. Novoselov, Vladimir I. Fal’ko, Luigi Colombo et al. · Nature Oct 2012 9,276
3 A comparison of normalization methods for high density oligonucleotide array data based on variance and bias Benjamin M. Bolstad, Rafael A. Irizarry, Magnus Åstrand et al. · Bioinformatics Open access 21 Jan 2003 8,511
4 Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma Tony S.K. Mok, Yi-Long Lung Cancer Wu, Sumitra Thongprasert et al. · New England Journal of Medicine Open access 19 Aug 2009 8,331
5 Fluorine in medicinal chemistry Sophie Purser, Peter R. Moore, Steve Swallow et al. · Chemical Society Reviews Review 13 Dec 2007 7,580
All 59 most cited papers, with filters and sorting

Which keywords describe research at AstraZeneca (United Kingdom)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Inflammation, Epidemiology, Treatment, Chemotherapy, Diagnosis, Clinical Trials, Targeted Therapy and Asthma.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology342▲ 2.1×100 topics
  2. Inflammation287▲ 3.4×75 topics
  3. Treatment224▲ 4.6×39 topics
  4. Diagnosis193▲ 5.2×32 topics
  5. Chemotherapy181▲ 6.4×22 topics
  6. Clinical Trials171▲ 6.4×17 topics
  7. Cancer147▲ 2.7×44 topics
  8. Management145▲ 4.5×25 topics
  9. Targeted Therapy143▲ 16×5 topics
  10. Genetics142▲ 5.0×18 topics
  11. Quality of Life139▲ 2.4×38 topics
  12. Cardiovascular Disease139▲ 3.0×35 topics
  13. Immunotherapy139▲ 4.8×19 topics
  14. Global Burden130▲ 6.0×11 topics
  15. Biomarkers126▲ 4.5×16 topics
  16. Asthma126▲ 32×2 topics
  17. Heart Failure125▲ 7.0×14 topics
  18. Immunology121▲ 28×2 topics
  19. Monoclonal Antibodies117▲ 33×3 topics
  20. Tumor Microenvironment116▲ 6.4×8 topics
  21. Cancer Therapy114▲ 5.0×17 topics
  22. Allergic Diseases113▲ 48×1 topic
  23. Eosinophils113▲ 48×1 topic
  24. Medicinal Chemistry110▲ 10×11 topics
  25. Breast Cancer108▲ 11×11 topics
  26. Glycosylation98▲ 22×3 topics
  27. Therapeutic Antibodies95▲ 34×2 topics
  28. Chronic Kidney Disease93▲ 9.2×9 topics
  29. Prognostic Factors91▲ 5.2×13 topics
  30. Pharmacokinetics87▲ 8.2×9 topics
  31. Respiratory87▲ 22×2 topics
  32. Genomic Profiling86▲ 21×2 topics
  33. COPD82▲ 31×1 topic
  34. spirometry82▲ 31×1 topic
  35. Treatment Guidelines81▲ 9.3×5 topics
  36. Monoclonal Antibody72▲ 33×2 topics
  37. Resistance Mechanisms70▲ 20×2 topics
  38. Cancer Immunotherapy70▲ 11×3 topics
  39. ALK Inhibitors69▲ 28×1 topic
  40. EGFR Mutations69▲ 28×1 topic

Which research topics does AstraZeneca (United Kingdom) publish most on?

By volume in 2022-now: Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Lung Cancer Treatments and Mutations and Computational Drug Discovery Methods.

Asthma and respiratory diseases: 113 fractional worksChronic Obstructive Pulmonary Disease (COPD) Research: 82 fractional worksLung Cancer Treatments a…69Lung Cancer Treatments and Mutations: 69 fractional worksComputational Drug Disco…64Computational Drug Discovery Methods: 64 fractional worksMonoclonal and Polyclonal Antibodies Research: 61 fractional worksCancer Immunotherapy and Biomarkers: 55 fractional worksHealth Systems, Economic…52Health Systems, Economic Evaluations, Quality of Life: 52 fractional worksCAR-T cell therapy resea…46CAR-T cell therapy research: 46 fractional worksHER2/EGFR in Cancer Rese…44HER2/EGFR in Cancer Research: 44 fractional worksDiabetes Treatment and M…42Diabetes Treatment and Management: 42 fractional works
PhysiologyPulmonary and Respiratory MedicineComputational Theory and MathematicsRadiology, Nuclear Medicine and Imaging3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Asthma and respiratory diseases Physiology 113 works
  2. 2 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 82 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 69 works
  4. 4 Computational Drug Discovery Methods Computational Theory and Mathematics 64 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 61 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 55 works
  7. 7 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 52 works
  8. 8 CAR-T cell therapy research Oncology 46 works
  9. 9 HER2/EGFR in Cancer Research Oncology 44 works
  10. 10 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 42 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available38.5%not open61.5%

World: 40% of research is openly available.

with international co-authors49.1%domestic only50.9%

World: 18% is written across borders.

How has AstraZeneca (United Kingdom)'s research output changed?

Output in 2022-2025 was 16% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is AstraZeneca (United Kingdom) as a percentage of every work published that year, 0.016% in 2024.

still counting0.020%0.040%AstraZeneca (United Kingdom)0.017% in 202519801990200020102020

Fractional works of AstraZeneca (United Kingdom) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting10%20%AstraZeneca (United Kingdom)16.8% in 2025all institutions10.0% in 2025200020102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 19.5% in 2019.

Other research institutions in Cambridge

All research institutions in Cambridge

Compare AstraZeneca (United Kingdom) with

Compare any two

Share AstraZeneca (United Kingdom)'s ranking

AstraZeneca (United Kingdom) on Science Explorer

A card with AstraZeneca (United Kingdom)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website2Each links back here and updates with every snapshot

Its overall standing, then the domains, fields and subfields where AstraZeneca (United Kingdom) is in the world's top ten or its top 1%. Each has an image of its own.

Overall

Domains

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about AstraZeneca (United Kingdom). Posts are plain text and can be reported.